Bloodstream Invasion Dominates Mortality in Invasive Candidiasis: Single-center Insights on Abdominal Origins, Antifungal Efficacy, and Biomarker-Driven Prognosis

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Invasive candidiasis (IC), particularly candidemia (56.7% mortality), faces diagnostic delays with blood cultures. Early identification of infection sources and biomarkers (PCT, IL-6, β-D-glucan) could enable prompt intervention. Methods A 12-month retrospective cohort study analyzed 223 hospitalized IC patients (2013–2024; incidence 31.9/100,000 patient-years) confirmed by sterile-site mycological evidence. Biomarkers, microbiology (BD/Vitek, CLSI susceptibility), and mortality predictors were assessed using regression and Kaplan-Meier analysis (SPSS). Results Patients were predominantly male (1.45:1), median age 60.1 years. Blood culture was the primary diagnostic specimen (33.5%); 35.2% were polymicrobial. Among 88 blood culture-positive cases, 77.3% detected solely in aerobic bottles (mean TTP 39.1h). C. albicans predominated (52.6% of isolates); resistance: fluconazole 5.8%, itraconazole 11.0%, voriconazole 7.0%. Primary infection sources: abdominal (46.6%), catheter (18.8%). Overall mortality was 46.2%, varying by focus: bloodstream infection (BSI: 70.3%), abdominal (43.2%), catheter (26.1%); joint infections: 0%. In single-species infections (n = 140), PCT demonstrated highest diagnostic value (AUC 0.827; sensitivity 0.667, specificity 0.862 at 0.778 µg/mL). Fluconazole conferred superior 90-day survival vs. caspofungin (0.815 vs 0.330; p < 0.001). Regression identified significant mortality predictors: PCT ≥ 0.778 ng/mL (OR 3.800, 95% CI 1.995–7.237, p < 0.001), IL-6 ≥ 25.375 pg/mL (OR 3.667, 95% CI 1.372–9.795, p = 0.01), BSIs (OR 4.431, 95% CI 2.438–8.054, p < 0.001), ICU admission (OR 2.351, 95% CI 1.269–4.356, p = 0.007); Fluconazole was protective (OR 0.102, 95% CI 0.033–0.316). Conclusion IC mortality (46.2%) was highest in BSIs (70.3%). Elevated PCT, IL-6, and BSI are significant predictors. Fluconazole is protective. C. albicans (52.6%) and abdominal infections (46.6%) predominated.

Article activity feed